<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00292500</url>
  </required_header>
  <id_info>
    <org_study_id>IP2004-06</org_study_id>
    <nct_id>NCT00292500</nct_id>
  </id_info>
  <brief_title>Efficacy of Automated Distal Vascular Anastomosis in Coronary Surgery: Phase II</brief_title>
  <official_title>Efficacy of Automated Distal Vascular Anastomosis in Coronary Surgery: Phase II</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardica, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardica, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This evaluation is designed to evaluate the feasibility of using an automated distal coronary
      anastomotic to facilitate grafting of the left internal mammary artery to the left anterio
      descending coronary artery during myocardial revascularization in patients with coronary
      artery disease requiring surgical intervention. The study is designed to assess the ability
      to compare the patency of grafts created using an automated device versus hand-sewn grafts of
      the same vessels in the same patient population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evaluation of automated distal anastomotic device as a surrogate for hand-sewn grafts for
      completion of arterial conduit anastomosis between the Left Internal Mammary Artery and Left
      Anterior Descending Artery among patients with coronary artery disease requiring surgical
      revascularization.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Cardica has terminated the development of the product for Business Reason.
  </why_stopped>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Coronary patency of index graft at the sixth post-operative month</measure>
    <time_frame>6 months post-op</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Establish preliminary safety profile</measure>
    <time_frame>6 months post-op</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">170</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>C-Port</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Automated distal anastomotic device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automated distal anastomotic device</intervention_name>
    <description>CABG</description>
    <arm_group_label>C-Port</arm_group_label>
    <other_name>C-Port xA Distal Anastomosis System</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 50 and 85 years (inclusive)

          -  Diagnostically confirmed coronary disease

          -  Ejection fraction &gt; 30%

          -  Tolerate contrast media

          -  Acceptable LIMA (conduit) and LAD (target)for grafting

          -  Life expectancy &gt; 1 year

        Exclusion Criteria:

          -  Refusal to give informed consent

          -  Unable to meet study travel and general health requirements

          -  Pregnancy

          -  Previous cardiac surgery

          -  NYHA Class IV

          -  Preoperative need for IABP

          -  Acute or chronic dialysis (creatinine &gt; 200mmolor 2.3 mg/dL) within 30 days of surgery

          -  Acute or suspected systemic infection

          -  Need for ongoing immunosuppressive therapy

          -  Recent history (&lt;2 weeks) of CVA

          -  Aspirin allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Gummert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Herzzentrum Leipzig Gmbh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinik f√ºr Herzchirurgie</name>
      <address>
        <city>Leipzig</city>
        <zip>D-04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 14, 2006</study_first_submitted>
  <study_first_submitted_qc>February 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 16, 2006</study_first_posted>
  <last_update_submitted>August 19, 2013</last_update_submitted>
  <last_update_submitted_qc>August 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CABG, anastomotic device; myocardial revascularization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

